Raman Spectroscopy and Skin Cancer

Launched by RENEE FARRELL · Apr 22, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help doctors understand skin cancer better, specifically focusing on two types called basal cell carcinoma and squamous cell carcinoma. The researchers want to see if an imaging technique called Raman Spectroscopy can help determine how large the tumors are and how much they have spread. During the study, a handheld device that uses laser light will be gently touched to the skin to take measurements.

To participate in this study, you need to have a confirmed diagnosis of one of the skin cancers mentioned and plan to receive a specific treatment called brachytherapy at the study site. The trial is open to both men and women aged 65 to 74. If you decide to join, you'll help researchers learn more about this new method, which could improve future treatments for skin cancer. However, individuals who are minors, unable to give consent, pregnant, or have certain medical conditions may not be eligible to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Histologically confirmed skin cancer (either basal cell carcinoma or squamous cell carcinoma)
• • Participants must plan to receive brachytherapy treatment for the skin cancer at the study site.
• • Ability to provide consent to the study.
• Exclusion Criteria:
• • Patient belongs to a vulnerable population (Minors (under 18 years old), Adults unable to consent, prisoners).
• • Lesions on the eyelid or in close proximity to the eye
• • Pregnant women, or women of childbearing age who refuse pregnancy testing.
• • Patient has pacemaker.